首页> 外文OA文献 >Efficacy and Safety of Imeglimin Monotherapy Versus Placebo in Japanese Patients With Type 2 Diabetes (TIMES 1): A Double-Blind, Randomized, Placebo-Controlled, Parallel-Group, Multicenter Phase 3 Trial

【2h】

Efficacy and Safety of Imeglimin Monotherapy Versus Placebo in Japanese Patients With Type 2 Diabetes (TIMES 1): A Double-Blind, Randomized, Placebo-Controlled, Parallel-Group, Multicenter Phase 3 Trial

机译：IMEGLIMIN单疗法对2型糖尿病患者的安慰剂的疗效和安全性（时间1）：双盲，随机，安慰剂控制，并联组，多中心3阶段试验

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Julie DUBOURG; Pascale FOUQUERAY; Carole THANG; Jean-Marie GROUIN; Kohjiro UEKI;
展开▼
作者单位

展开▼
年度 2021
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献

1. Efficacy and safety of once-weekly semaglutide monotherapy versus placebo in patients with type 2 diabetes (SUSTAIN 1): a double-blind, randomised, placebo-controlled, parallel-group, multinational, multicentre phase 3a trial [J] . Sorli Christopher, Harashima Shin-ichi, Tsoukas George M., The lancet. Diabetes & endocrinology. . 2017,第4期

机译：患有2型糖尿病患者的一次每周半蛋白质单药治疗的疗效和安全性（持续1）：双盲，随机，安慰剂控制，平行群，跨国，多元相3A试验
2. Efficacy and safety of monotherapy with the novel sodium/glucose cotransporter-2 inhibitor tofogliflozin in Japanese patients with type 2 diabetes mellitus: a combined Phase 2 and 3 randomized, placebo-controlled, double-blind, parallel-group comparative study [J] . Kohei Kaku, Hirotaka Watada, Yasuhiko Iwamoto, Cardiovascular Diabetology . 2014,第1期

机译：新型钠/葡萄糖共转运蛋白2抑制剂tofogliflozin在日本2型糖尿病患者中单药治疗的有效性和安全性：一项2期和3期随机，安慰剂对照，双盲，平行组比较研究
3. Efficacy and safety of dapagliflozin as a monotherapy for type 2 diabetes mellitus in Japanese patients with inadequate glycaemic control: A phase II multicentre, randomized, double-blind, placebo-controlled trial [J] . Diabetes, obesity & metabolism . 2013,第5期

机译：达格列净在血糖控制不良的日本患者中作为2型糖尿病单一疗法的疗效和安全性：II期多中心，随机，双盲，安慰剂对照试验
4. A DOUBLE-BLIND RANDOMIZED PLACEBO-CONTROLLED CLINICAL TRIAL TO INVESTIGATE THE EFFICACY OF TIAMULIN IN THE CONTROL OF PORCINE PROLIFERATIVE ENTEROPATHY (PPE) AND PORCINE COLONIC SPIROCHAETOSIS (PCS) UNDER FIELD CONDITIONS [C] . J. Haugegaard, K. Moller, T.K. Jensen, Congress of the International Pig Veterinary Society . 2000

机译：一种双盲随机安慰剂对照临床试验，探讨硫霉素在野生植物中猪增殖肠病（PPE）和猪结肠螺旋肌肤症（PCS）的疗效
5. A Phase II, Randomized, Double-Blind, Placebo-Controlled Trial of Fish Oil (Eicosapentaenoic Acid and Docosahexaenoic Acid) on Lung and Systemic Inflammation in Patients with Acute Lung Injury. [D] . Stapleton, Renee Doney. 2010

机译：鱼油（二十碳五烯酸和二十二碳六烯酸）对急性肺损伤患者的肺和全身炎症的II期，随机，双盲，安慰剂对照试验。
6. Efficacy and safety of monotherapy with the novel sodium/glucose cotransporter-2 inhibitor tofogliflozin in Japanese patients with type 2 diabetes mellitus: a combined Phase 2 and 3 randomized placebo-controlled double-blind parallel-group comparative study [O] . Kohei Kaku, Hirotaka Watada, Yasuhiko Iwamoto, 2014

机译：新型钠/葡萄糖共转运蛋白2抑制剂tofogliflozin在日本2型糖尿病患者中单药治疗的有效性和安全性：一项2期和3期随机安慰剂对照双盲平行组比较研究
7. Efficacy and Safety of Imeglimin Monotherapy Versus Placebo in Japanese Patients With Type 2 Diabetes (TIMES 1): A Double-Blind, Randomized, Placebo-Controlled, Parallel-Group, Multicenter Phase 3 Trial [O] . Julie DUBOURG, Pascale FOUQUERAY, Carole THANG, 2021

机译：IMEGLIMIN单疗法对2型糖尿病患者的安慰剂的疗效和安全性（时间1）：双盲，随机，安慰剂控制，并联组，多中心3阶段试验

Efficacy and Safety of Imeglimin Monotherapy Versus Placebo in Japanese Patients With Type 2 Diabetes (TIMES 1): A Double-Blind, Randomized, Placebo-Controlled, Parallel-Group, Multicenter Phase 3 Trial

著录项

引文网络

相似文献

相关主题

期刊订阅